COVID-19 vaccine booster shots, but may vote on a narrower approval for older adults later on Friday.The panel voted overwhelmingly against approving boosters for Americans age 16 and older, potentially undermining the Biden administration’s plan to roll out third shots of the Pfizer/BioNTech vaccine as soon as next week.
COVID-19 booster debate in U.S. heads to FDA vaccine advisory committee But there was widespread support among panelists for a third dose for older Americans, who are at higher risk of severe COVID-19 and may be more likely to have waning immunity after the first rounds of shots.
FDA officials said that a vote to recommend approval for such groups was possible later on Friday.The FDA will take the panel’s recommendation.